BioSyent Market Cap

BioSyent has a market cap or net worth of $97.16 million as of June 30, 2025. Its market cap has increased by 25.64% in one year.

Market Cap

97.16M

Enterprise Value

85.15M

Revenue

26.63M

Ranking

n/a

PE Ratio

17.86

Stock Price

$8.67

Market Cap Chart

Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 97.16M, an increase of 924.77%. That is a compound annual growth rate of 8.60%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	97.16M	9.48%
Dec 31, 2024	88.75M	8.08%
Dec 29, 2023	82.11M	31.23%
Dec 30, 2022	62.57M	-23.01%
Dec 30, 2021	81.27M	2.23%
Dec 31, 2020	79.49M	24.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	779.84M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Glass House Brands	459.12M
American Oncology Network	422.12M
CytoDyn	375.37M

Market Cap Rankings